Identifying high risk patients

As reported here previously, Israel’s Medial EarlySign has partnered with Israeli health company Maccabi to identify its members with a high risk of influenza complications. The system will now be used to fast-track testing and treatment if these patients report coronavirus symptoms to Maccabi.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *